Cargando…

Linking Cerebrovascular Dysfunction to Age-Related Hearing Loss and Alzheimer’s Disease—Are Systemic Approaches for Diagnosis and Therapy Required?

Alzheimer’s disease (AD), the most common cause of dementia in the elderly, is a neurodegenerative disorder associated with neurovascular dysfunction, cognitive decline, and the accumulation of amyloid β peptide (Aβ) in the brain and tau-related lesions in neurons termed neurofibrillary tangles (NFT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Förster, Carola Y., Shityakov, Sergey, Scheper, Verena, Lenarz, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688145/ https://www.ncbi.nlm.nih.gov/pubmed/36421731 http://dx.doi.org/10.3390/biom12111717

Ejemplares similares

The Conspicuous Link between Ear, Brain and Heart–Could Neurotrophin-Treatment of Age-Related Hearing Loss Help Prevent Alzheimer’s Disease and Associated Amyloid Cardiomyopathy?
por: Shityakov, Sergey, et al.
Publicado: (2021)

Editorial: Deafness, aging and Alzheimer's disease: Neurobiological links and therapy options
por: Juiz, José M., et al.
Publicado: (2023)

Local Long-Term Inner Ear Drug Delivery in Normal Hearing Guinea Pig—An Animal Model to Develop Preventive Treatment for Noise-Induced Hearing Loss
por: Malfeld, Kathrin, et al.
Publicado: (2022)

In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
por: Shityakov, Sergey, et al.
Publicado: (2014)

In silico predictive model to determine vector-mediated transport properties for the blood–brain barrier choline transporter
por: Shityakov, Sergey, et al.
Publicado: (2014)

Pharmacokinetic Delivery and Metabolizing Rate of Nicardipine Incorporated in Hydrophilic and Hydrophobic Cyclodextrins Using Two-Compartment Mathematical Model
por: Shityakov, Sergey, et al.
Publicado: (2013)

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
por: Shityakov, Sergey, et al.
Publicado: (2021)

Cerebrovascular dysfunction links aging to neurological disease
por: Van Skike, Candice E., et al.
Publicado: (2020)

Prevention of Noise-Induced Hearing Loss In Vivo: Continuous Application of Insulin-like Growth Factor 1 and Its Effect on Inner Ear Synapses, Auditory Function and Perilymph Proteins
por: Malfeld, Kathrin, et al.
Publicado: (2022)

Homocysteine Induced Cerebrovascular Dysfunction: A Link to Alzheimer’s Disease Etiology
por: Kamat, P.K, et al.
Publicado: (2015)

α-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies
por: Shityakov, Sergey, et al.
Publicado: (2012)

Glucocorticoids and endothelial cell barrier function
por: Salvador, Ellaine, et al.
Publicado: (2013)

Gene expression profiles and protein–protein interaction network analysis in AIDS patients with HIV-associated encephalitis and dementia
por: Shityakov, Sergey, et al.
Publicado: (2015)

The Role of Clusterin Transporter in the Pathogenesis of Alzheimer’s Disease at the Blood–Brain Barrier Interface: A Systematic Review
por: Fareed, Muhammad Mazhar, et al.
Publicado: (2022)

Evaluation and Prediction of the HIV-1 Central Polypurine Tract Influence on Foamy Viral Vectors to Transduce Dividing and Growth-Arrested Cells
por: Shityakov, Sergey, et al.
Publicado: (2014)

Blood–brain barrier transport studies, aggregation, and molecular dynamics simulation of multiwalled carbon nanotube functionalized with fluorescein isothiocyanate
por: Shityakov, Sergey, et al.
Publicado: (2015)

Modeling of shotgun sequencing of DNA plasmids using experimental and theoretical approaches
por: Shityakov, Sergey, et al.
Publicado: (2020)

In Silico Modeling of Indigo and Tyrian Purple Single-Electron Nano-Transistors Using Density Functional Theory Approach
por: Shityakov, Sergey, et al.
Publicado: (2017)

Three-dimensional quantitative structure–activity relationship and docking studies in a series of anthocyanin derivatives as cytochrome P450 3A4 inhibitors
por: Shityakov, Sergey, et al.
Publicado: (2014)

Frailty Syndrome and Oxidative Stress as Possible Links Between Age-Related Hearing Loss and Alzheimer’s Disease
por: Alvarado, Juan Carlos, et al.
Publicado: (2022)

Cerebrovascular disease in ageing and Alzheimer’s disease
por: Love, Seth, et al.
Publicado: (2015)

APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
por: Brandon, Jason A., et al.
Publicado: (2018)

Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer’s disease
por: Asby, Daniel, et al.
Publicado: (2021)

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
por: Ramos-Cejudo, Jaime, et al.
Publicado: (2018)

Hearing Loss and Kidney Dysfunction: Finding a Unifying Diagnosis
por: Iruku, Praveena, et al.
Publicado: (2013)

Oxidative Stresses and Mitochondrial Dysfunction in Age-Related Hearing Loss
por: Fujimoto, Chisato, et al.
Publicado: (2014)

Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
por: Humpel, Christian
Publicado: (2011)

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2018)

Acute Profound Sensorineural Hearing Loss After COVID-19 Pneumonia
por: Degen, Chantal, et al.
Publicado: (2020)

The Protective Effects of Neurotrophins and MicroRNA in Diabetic Retinopathy, Nephropathy and Heart Failure via Regulating Endothelial Function
por: Shityakov, Sergey, et al.
Publicado: (2022)

Disentangling the multiple links between renal dysfunction and cerebrovascular disease
por: Kelly, Dearbhla, et al.
Publicado: (2020)

Role of Milk-Derived Antibacterial Peptides in Modern Food Biotechnology: Their Synthesis, Applications and Future Perspectives
por: Khan, Muhammad Usman, et al.
Publicado: (2018)

Ionization States, Cellular Toxicity and Molecular Modeling Studies of Midazolam Complexed with Trimethyl-β-Cyclodextrin
por: Shityakov, Sergey, et al.
Publicado: (2014)

Hearing loss in aging
por: dos Santos Baraldi, Giovana, et al.
Publicado: (2015)

ACEMg-mediated hearing preservation in cochlear implant patients receiving different electrode lengths (PROHEARING): study protocol for a randomized controlled trial
por: Scheper, Verena, et al.
Publicado: (2016)

Correlation of Electrically Evoked Compound Action Potential Amplitude Growth Function Slope and Anamnestic Parameters in Cochlear Implant Patients—Identification of Predictors for the Neuronal Health Status
por: Gärtner, Lutz, et al.
Publicado: (2021)

CAN HEARING AIDS DELAY THE ONSET OF ALZHEIMER’S AND OTHER AGE-RELATED CONDITIONS AMONG ADULTS WITH HEARING LOSS?
por: Mahmoudi, Elham, et al.
Publicado: (2019)

Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients
por: Scheper, Verena, et al.
Publicado: (2020)

Alzheimer’s Disease, Hearing Loss, and Deviance Detection
por: Pérez-González, David, et al.
Publicado: (2022)

Weakening of interaction networks with aging in tip-link protein induces hearing loss
por: Garg, Surbhi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2v2hnvg946180ttoc2v6nk7len